Clinical trial
Safety and Efficacy of Transplantation of Specific Populations of Stem Cells and Mesenchymal Stem Cells for the Treatment of Cerebral Palsy
NCT03078621 is registered in ClinicalTrials.gov with Stem Cells Arabia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Transplantation of Specific Populations of Stem Cells and Mesenchymal Stem Cells for the Treatment of Cerebral Palsy
- Lead sponsor
- Stem Cells Arabia
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2016
- Completion date
- January 31, 2021
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.